» Articles » PMID: 28930148

Elongation of Axon Extension for Human IPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Sep 21
PMID 28930148
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Optic neuropathies, such as glaucoma and Leber's hereditary optic neuropathy (LHON) lead to retinal ganglion cell (RGC) loss and therefore motivate the application of transplantation technique into disease therapy. However, it is a challenge to direct the transplanted optic nerve axons to the correct location of the retina. The use of appropriate scaffold can promote the proper axon growth. Recently, biocompatible materials have been integrated into the medical field, such as tissue engineering and reconstruction of damaged tissues or organs. We, herein, utilized nano-imprinting to create a scaffold mimicking the in vitro tissue microarchitecture, and guiding the axonal growth and orientation of the RGCs. We observed that the robust, long, and organized axons of human induced pluripotent stem cell (iPSC)-derived RGCs projected axially along the scaffold grooves. The RGCs grown on the scaffold expressed the specific neuronal biomarkers indicating their proper functionality. Thus, based on our in vitro culture system, this device can be useful for the neurophysiological analysis and transplantation for ophthalmic neuropathy treatment.

Citing Articles

Progress in photoreceptor replacement therapy for retinal degenerative diseases.

Du Y, Shen Y Cell Insight. 2025; 4(1):100223.

PMID: 39877255 PMC: 11773227. DOI: 10.1016/j.cellin.2024.100223.


Unlocking the potential for optic nerve regeneration over long distances: a multi-therapeutic intervention.

Liu Z, Zhou L, Sun Y, Ma Y, Liu C, Zhang B Front Neurol. 2025; 15():1526973.

PMID: 39850731 PMC: 11754882. DOI: 10.3389/fneur.2024.1526973.


Engineered bio-functional material-based nerve guide conduits for optic nerve regeneration: a view from the cellular perspective, challenges and the future outlook.

Obeng E, Shen B, Wang W, Xie Z, Zhang W, Li Z Regen Biomater. 2025; 12:rbae133.

PMID: 39776856 PMC: 11703557. DOI: 10.1093/rb/rbae133.


Hereditary Optic Neuropathies: A Systematic Review on the Interplay between Biomaterials and Induced Pluripotent Stem Cells.

Ladero M, Reche-Sainz J, Gallardo M Bioengineering (Basel). 2024; 11(1).

PMID: 38247929 PMC: 10813088. DOI: 10.3390/bioengineering11010052.


Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases.

Mahaling B, Low S, Ch S, Addi U, Ahmad B, Connor T Pharmaceutics. 2023; 15(7).

PMID: 37514191 PMC: 10383092. DOI: 10.3390/pharmaceutics15072005.


References
1.
Meyer J, Howden S, Wallace K, Verhoeven A, Wright L, Capowski E . Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells. 2011; 29(8):1206-18. PMC: 3412675. DOI: 10.1002/stem.674. View

2.
Sluch V, Davis C, Ranganathan V, Kerr J, Krick K, Martin R . Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line. Sci Rep. 2015; 5:16595. PMC: 4643248. DOI: 10.1038/srep16595. View

3.
Wong I, Poon M, Pang R, Lian Q, Wong D . Promises of stem cell therapy for retinal degenerative diseases. Graefes Arch Clin Exp Ophthalmol. 2011; 249(10):1439-48. PMC: 3178027. DOI: 10.1007/s00417-011-1764-z. View

4.
Mattotti M, Alvarez Z, Ortega J, Planell J, Engel E, Alcantara S . Inducing functional radial glia-like progenitors from cortical astrocyte cultures using micropatterned PMMA. Biomaterials. 2011; 33(6):1759-70. DOI: 10.1016/j.biomaterials.2011.10.086. View

5.
Durnaoglu S, Genc S, Genc K . Patient-specific pluripotent stem cells in neurological diseases. Stem Cells Int. 2011; 2011:212487. PMC: 3138107. DOI: 10.4061/2011/212487. View